Antimalarial Drug Resistance Surveillance in China, 2016-2020

Fang Huang; Hui Liu; He Yan; Shuisen Zhou; Zhigui Xia

doi:10.46234/ccdcw2021.099

Antimalarial Drug Resistance Surveillance in China, 2016-2020

China CDC Wkly. 2021 Apr 23;3(17):366-371. doi: 10.46234/ccdcw2021.099.

Authors

Fang Huang¹, Hui Liu², He Yan¹, Shuisen Zhou¹, Zhigui Xia¹

Affiliations

¹ National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, WHO Collaborating Center for Tropical Diseases, National Centre for International Research on Tropical Diseases, NHC Key Laboratory of Parasite and Vector Biology (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention), Shanghai, China.
² Yunnan Institute of Parasitic Diseases, Puer, China.

No abstract available

Grants and funding

The Natural Science Foundation of Shanghai (No. 18ZR1443400), the Fifth Round of Three-Year Public Health Action Plan of Shanghai (No. GWV-10.1-XK13), and the National Important Scientific & Technological Project (2018ZX10101002–002).